Disruption of cancer cell replication by alternating electric fields. - Wikidata - wikimedia - TriplyDB

Disruption of cancer cell replication by alternating electric fields.

Disruption of cancer cell replication by alternating electric fields.

http://www.wikidata.org/entity/Q34318661

about

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit An Overview of Sub-Cellular Mechanisms Involved in the Action of TTFields.Tumor treating fields: a novel treatment modality and its use in brain tumors Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage Calcium-independent disruption of microtubule dynamics by nanosecond pulsed electric fields in U87 human glioblastoma cells.Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices.Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling.A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells.Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields).TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection Predicting the electric field distribution in the brain for the treatment of glioblastoma.Tumor treating fields: concept, evidence and future.Tumor treating fields: a new frontier in cancer therapy.The effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells.Recurrent malignant gliomas.Cancer cell proliferation is inhibited by specific modulation frequencies Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields.Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study.Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.Engineering a 3D microfluidic culture platform for tumor-treating field application.Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy.Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.Microtubule ionic conduction and its implications for higher cognitive functions.

P2860

Q24676928-8BBB0EE3-266E-4DED-B90E-45C62FD2C6C1 Q26770399-1DEA507A-562D-4855-A27E-063AB92727EB Q26852232-33073F32-986F-4081-88DA-60AF17D9D1DD Q27303864-AF964768-B17D-419A-B64C-93D29C13ADE7 Q27308744-56166EE1-9E41-429F-AC1C-6E7DD0E06F26 Q28067498-98A14274-D82A-4111-83E8-FAEB367CCC3C Q28073779-691884C9-F284-41DF-8503-5E36F4E72307 Q28078632-C72912E0-3772-4F8B-BF3E-C4B050D7D454 Q28555006-2BE7BCF9-47EE-463A-9220-CAA2704ECB84 Q30365091-5A8D01F0-810C-40C0-81CD-561DCDB24782 Q30448586-E44F7459-33D6-48F6-9003-F51076210F49 Q30856517-187719B3-CF52-4F59-9DFE-03C3230BCE83 Q31130812-0EEF7B8B-5664-4155-A18F-91EB51D1BE19 Q33236905-DF09B7C3-83EC-4DE8-A3EB-28BE9A450AB1 Q33398646-88D2F4ED-524A-4F69-882B-5EF4DBDD4F42 Q33584376-0F217855-D29C-4466-A166-610B5322C18F Q33678976-82160B95-48AA-4ECA-A4B5-E48C74738789 Q34045228-5B1127D0-3F7E-4042-AB5F-49B329641FEC Q34063130-A52411E0-AF03-42F6-A85F-6BEDC1B43E02 Q34183195-143E6FAF-8B07-4094-8AE7-9AAC48DD76ED Q34343822-50F1B0DA-9172-44F6-ADF8-D5DEF07FD0F0 Q34348124-27B976FD-7F78-420F-8824-07F73C898DA3 Q34438507-A73DEF51-3632-4280-9091-8E729FE24F44 Q34634038-087C33F8-01BD-4073-AFE9-CCDA33E1201F Q34644506-DE89687A-7B01-4FDD-9E25-8C6FEEAD744B Q35863183-CBF70BAE-322B-4D18-A6F4-2EB25C4FF46D Q35891430-03BC71C5-43D5-428B-9510-51AE47413A4F Q35970661-C7A1F027-B00D-4BFE-8BDC-A7F2D1C3E367 Q36151109-7871816E-3AAD-4526-8CA6-440FCFCE546D Q36181437-AB850729-A9BA-4FAD-B4EE-B4B9BB256C90 Q36235790-83F42D07-01E3-4742-9435-569AB4EE96BE Q36399129-6F4419ED-CDE7-4742-9A6E-0BD785FDB780 Q36928486-D00EB780-6B71-44C0-8F95-561439EC22B5 Q37166421-630EC8E0-BF99-4EA5-AD6B-6061EE412C84 Q37194638-031169D1-E866-4EC4-9306-78C95EE25C93 Q37394107-9906F4C2-A065-4FDF-97AD-00FDCE9D986F Q37418672-053A5C78-898F-45F1-B26F-08010F54D8BE Q37641759-6422E19F-6D4F-4B08-B216-0842A042461C Q37662196-FCF2997E-16C6-4980-9779-90E40F5797C7 Q37768755-B083F2F7-25CD-47FF-98C3-4431BE6B2BAE

P2860

Disruption of cancer cell replication by alternating electric fields.

http://www.wikidata.org/entity/Q34318661

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Disruption of cancer cell replication by alternating electric fields.

@ast

Disruption of cancer cell replication by alternating electric fields.

@en

Disruption of cancer cell replication by alternating electric fields.

@nl

type

label

Disruption of cancer cell replication by alternating electric fields.

@ast

Disruption of cancer cell replication by alternating electric fields.

@en

Disruption of cancer cell replication by alternating electric fields.

@nl

prefLabel

Disruption of cancer cell replication by alternating electric fields.

@ast

Disruption of cancer cell replication by alternating electric fields.

@en

Disruption of cancer cell replication by alternating electric fields.

@nl

P1433

Q34318661-43ABE108-58B2-4EFB-B933-BBDA0DB1BEE8

P1476

Q34318661-34288E11-3E86-48A5-9A8D-0DF0838E2118

P2093

Q34318661-18242367-975F-4637-80D5-364D57C52CAE

Q34318661-29EF1B65-6DE1-4A58-A8C6-80D04B1F8A0D

Q34318661-2AAEF908-875C-4F59-A044-6E9110110552

Q34318661-3EFB28D9-D35C-4C62-B83B-37A0C281ED1D

Q34318661-7B663FD7-73AB-4D57-8BA4-E74A7D82157C

Q34318661-89BF79F0-FC59-45A4-82FC-DA9687A84100

Q34318661-DA000688-CF77-46AF-A3EA-F5B9D21B0F9B

Q34318661-EA62244A-7F2A-4A1B-B85C-47BC1E2BB388

P304

Q34318661-92CB43B3-CBE6-4DEA-BB90-2F8BB53B66DC

P31

Q34318661-877AA520-D7B3-4574-B22B-0B44C8525D2D

P356

Q34318661-8795AE8B-8808-4D54-B592-16AB7884AD79

P407

Q34318661-B14CA625-0E66-489A-9FBF-488DAB7312C0

P433

Q34318661-3D3883A5-5E02-427D-9E1C-3B494F979BA6

P478

Q34318661-F84BD9DD-953C-4DEA-B4CF-0E509E0DD752

P577

Q34318661-6A91D965-ABCB-4158-8B42-013788533C87

P698

Q34318661-9E96A5F3-47F5-4745-ABCA-5E8B8ECA39FB

P356

0008-5472.CAN-04-0083

P1433

Cancer Research

P1476

Disruption of cancer cell replication by alternating electric fields.

@en

P2093

Aviran Itzhaki

http://www.w3.org/2001/XMLSchema#string

Eilon D Kirson

http://www.w3.org/2001/XMLSchema#string

Erez Dekel

http://www.w3.org/2001/XMLSchema#string

Rachel Schatzberger

http://www.w3.org/2001/XMLSchema#string

Rosa Schneiderman

http://www.w3.org/2001/XMLSchema#string

Yoram Palti

http://www.w3.org/2001/XMLSchema#string

Yoram Wasserman

http://www.w3.org/2001/XMLSchema#string

Zoya Gurvich

http://www.w3.org/2001/XMLSchema#string

P304

3288-3295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-0083

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15126372

http://www.w3.org/2001/XMLSchema#string